Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuehao Cui

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Ophthalmology Science|May 25, 2026
Integrating Polygenic Risk and Ocular Phenotyping Reveals an Axial-Length-Dominant Mechanism in High and Extreme High MyopiaJingwen Hui, Xuehao Cui, Qiuchen Zhao, et al.
International Journal of Biological Sciences|May 20, 2026
Cathepsin H drives hypoxia-associated inflammatory and angiogenic programs in diabetic retinopathy and represents a potential therapeutic targetXuehao Cui, Qiuchen Zhao, Jingwen Hui, et al.
Iscience|June 4, 2026
Integrative omics identify NID2 as a therapeutic target linking depression and colorectal cancer in humansLi Huang, Ji Wang, Haodong Tian, et al.
Frontiers in Immunology|May 25, 2026
Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical managementMingjun Shao, Tong Wang, Limei Ji, et al.
Survey of Ophthalmology|April 30, 2026
Omics in hereditary optic neuropathies:A systematic review of clinical studies with an integrated point of viewRaoul K Khanna, Xuehao Cui, David Chuen Soong Wong, et al.
JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Ophthalmology Science|May 25, 2026
Integrating Polygenic Risk and Ocular Phenotyping Reveals an Axial-Length-Dominant Mechanism in High and Extreme High MyopiaJingwen Hui, Xuehao Cui, Qiuchen Zhao, et al.
International Journal of Biological Sciences|May 20, 2026
Cathepsin H drives hypoxia-associated inflammatory and angiogenic programs in diabetic retinopathy and represents a potential therapeutic targetXuehao Cui, Qiuchen Zhao, Jingwen Hui, et al.
Iscience|June 4, 2026
Integrative omics identify NID2 as a therapeutic target linking depression and colorectal cancer in humansLi Huang, Ji Wang, Haodong Tian, et al.
Frontiers in Immunology|May 25, 2026
Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical managementMingjun Shao, Tong Wang, Limei Ji, et al.
Survey of Ophthalmology|April 30, 2026
Omics in hereditary optic neuropathies:A systematic review of clinical studies with an integrated point of viewRaoul K Khanna, Xuehao Cui, David Chuen Soong Wong, et al.
JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.
Pageof 3